Pharmaceuticals
Ascentage Pharma Announces Clearances for Three Phase Ib/II Clinical Studies of APG-2575 in China and the U.S., Beginning Simultaneous Clinical Development in Three Hematologic Malignancy Indications
SUZHOU, China and ROCKVILLE, MD., March 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that two clinical studies of...
2020-03-09 20:00
1996
NAGASE/Nagase Medicals and Osaka University Launch Joint Research Program
TOKYO, March 5, 2020 /PRNewswire/ -- NAGASE & CO., LTD. ("NAGASE") and Osaka University ("OU") have launched DDS Products Joint Development Research Chair, a course dedicated to research in the development of production methods of liposomal formulations and lipid-based nanoparticulate formulation...
2020-03-05 14:00
1161
Zuellig Pharma acquires Alliance Pharma (Cambodge) in Cambodia to strengthen Indochina presence
SINGAPORE, March 5, 2020 /PRNewswire/ -- Zuellig Pharma, a leading healthcare
services provider inAsia, has announced that it has acquired a controlling
stake in Alliance Pharma (Cambodge), a leading healthcare distributor ofCambodia
.
2020-03-05 08:15
5958
NDA Filing for Luye Pharma's Antidepressant Drug LY03005 Accepted by the U.S. FDA
SHANGHAI, March. 4, 2020 /PRNewswire/ -- Luye Pharma Group has announced that the U.S. Food and Drug Administration (FDA) has reviewed and accepted the filing of a New Drug Application (NDA) for LY03005, a new chemical drug for the treatment of major depressive disorder. LY03005 is the company's ...
2020-03-04 21:27
2111
New Disinfection Spray From Lipidor and Aurena Laboratories
STOCKHOLM, March 4, 2020 /PRNewswire/ -- In connection with the ongoing outbreak of Covid-19, caused by the new coronavirus, demand for disinfectants has snowballed and many products have suffered from supply shortages. Lipidor (Nasdaq First North: LIPI) has previously developed a spray for hand ...
2020-03-04 15:20
1738
DoctorOnCall Partners Merchantrade Money to Offer Convenient Digital Health Service to App Users
KUALA LUMPUR, Malaysia, March 4, 2020 /PRNewswire/ -- Recently, DoctorOnCall has signed a Partnership agreement with Merchantrade Asia Sdn Bhd (Merchantrade). This partnership will allow users of the Merchantrade Money application to access online consultations with accredited doctors and e-...
2020-03-04 13:30
5413
Merck's New LANEXO™ System to Improve Scientists' Productivity in the Lab
- First-to-market digital laboratory informatics solution with RFID labels for rapid access to reagent data - Improves inventory management; facilitates regulatory compliance; minimizes reagent waste - Reduces time on repetitive, error-prone tasks DARMSTADT, Germany, March 4, 2020 /PRNewswi...
2020-03-04 03:00
3624
China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results
BEIJING, March 3, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its fourth quarter and fiscal year 2019 fi...
2020-03-03 21:30
7821
Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800
Human Trials Planned for April; One Million Doses Expected by Year End PLYMOUTH MEETING, Pennsylvania, March 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infe...
2020-03-03 21:00
3677
CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation with Techorizon
VERONA, Italy, March 3, 2020 /PRNewswire/ -- CROMSOURCE announced today the achievement of a significant milestone in the digital management of clinical research projects for their clients. InFebruary 2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced TheClinical digital...
2020-03-03 20:00
2681
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will offer a wide range of services from c...
2020-03-03 03:00
1269
Bactiguard Completes Acquisition of Vigilenz
STOCKHOLM, March 2, 2020 /PRNewswire/ -- Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on4 February 2020. All conditions precedent have been fulfilled and the first part...
2020-03-02 22:06
9012
Yuyu Pharma announces review of compliance policies and procedures
SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implement...
2020-03-02 22:00
1232
China Pharmaceutical Holdings Co., Ltd. Launched A New Product
HAIKOU CITY, China, March 2, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its subsidiary, Hainan ...
2020-03-02 20:00
6036
ConvaTec sharpens focus on Asia Pacific and emerging markets
SINGAPORE, March 2, 2020 /PRNewswire/ -- ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the forefront of its new operating model by establishing a fully integrated business unit called the Global Emerging Markets (GEM), according to...
2020-03-02 18:06
9806
Yuyu Pharma, Laying the foundation for establishing a global-level compliance system with one of Korea's top law firms
SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implement...
2020-03-02 17:00
1333
ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, disease progression ...
2020-03-02 15:02
5185
Sihuan Pharmaceutical Announces Clinical Research of Favipiravir, Co-Developed with the Academy of Military Medical Sciences of the People's Liberation Army, Has Commenced
HONG KONG, March 2, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the clinical research of Favipiravir tablet, which was co-developed by the Group and t...
2020-03-02 14:15
7724
Luminex Corporation Submits VERIGENE(R) II Respiratory Flex Assay for FDA Clearance
AUSTIN, Texas, March 2, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an application to the U.S. Food and Drug Administration (FDA) for 510(k) clearance of the VERIGENE® II RespiratoryFlex Assay, the second VERIGENE II assay to be submitted...
2020-03-02 10:00
6046
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma
SINGAPORE, Feb. 27, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company's investigational CD30-directed autologous chimeric antigen receptor T cell (CD30 CAR-T) therapy has been gran...
2020-02-27 20:00
2214
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5608
